Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Phase 2 Completed
27 enrolled 12 charts
VISMONEO
Phase 2 Completed
55 enrolled
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer
Phase 2 Completed
40 enrolled 22 charts
REPAINT
Phase 2 Completed
55 enrolled 19 charts
TACTI-002
Phase 2 Completed
187 enrolled 13 charts
ANICCA
Phase 2 Completed
35 enrolled 15 charts
Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer
Phase 2 Completed
138 enrolled 42 charts
Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 2 Completed
76 enrolled 12 charts
Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Phase 2 Completed
53 enrolled
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
18 enrolled 12 charts
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
Phase 2 Completed
6 enrolled 19 charts
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.
Phase 2 Completed
104 enrolled 33 charts
Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
Phase 2 Completed
13 enrolled 13 charts
CONGRATS
Phase 2 Completed
68 enrolled
A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine Kinase Inhibitors.
Phase 2 Completed
22 enrolled
NF1NAC
Phase 2 Completed
5 enrolled 10 charts
A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases
Phase 2 Completed
108 enrolled 13 charts
Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Phase 2 Completed
39 enrolled
UTOPIA-1
Phase 2 Completed
11 enrolled
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
Phase 2 Completed
16 enrolled
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
Phase 2 Completed
48 enrolled 7 charts
A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC
Phase 2 Completed
118 enrolled
GAZAI
Phase 2 Completed
89 enrolled
Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Phase 2 Completed
47 enrolled
COMPANION-003
Phase 2 Completed
49 enrolled
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 2 Completed
154 enrolled
Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis
Phase 2 Completed
30 enrolled
Therapy for Children With Advanced Stage Neuroblastoma
Phase 2 Completed
153 enrolled 12 charts
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Phase 2 Completed
62 enrolled 10 charts
Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
Phase 2 Completed
45 enrolled 9 charts
AXMUS-C
Phase 2 Completed
52 enrolled 12 charts
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Phase 2 Completed
21 enrolled
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Phase 2 Completed
40 enrolled 15 charts
PAMELA70
Phase 2 Completed
72 enrolled 7 charts
Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab
Phase 2 Completed
67 enrolled
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
Phase 2 Completed
9 enrolled 9 charts
Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors
Phase 2 Completed
20 enrolled
TICE
Phase 2 Completed
101 enrolled
CURIEFOCALE
Phase 2 Completed
18 enrolled
FORTE
Phase 2 Completed
477 enrolled
ASTEROID
Phase 2 Completed
106 enrolled
TEC-ORL
Phase 2 Completed
13 enrolled
Radium-223 in Combination With Enzalutamide
Phase 2 Completed
45 enrolled
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Phase 2 Completed
180 enrolled 14 charts
AASUR in High Risk Prostate Cancer
Phase 2 Completed
64 enrolled 7 charts
TBCRC042
Phase 2 Completed
84 enrolled
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
20 enrolled 12 charts
CAPRI
Phase 2 Completed
123 enrolled
EndoBARR
Phase 2 Completed
30 enrolled 7 charts
A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer
Phase 2 Completed
28 enrolled